Glenview Capital Management — TAK Trade History
Quarter-by-quarter changes in the TAKEDA PHARMACEUTICAL CO LTD position · CUSIP 874060205
Sold outFirst seen: 2019 Q1
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | — | — | — | — | — | — |
| 2026 Q1 | 2026-05-15 | — | — | — | — | — | — |
| 2025 Q4 | 2026-02-17 | — | — | — | — | — | — |
| 2025 Q3 | 2025-11-14 | — | — | — | — | — | — |
| 2025 Q2 | 2025-08-14 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-15 | — | — | — | — | — | — |
| 2024 Q4 | 2025-02-14 | — | — | — | — | — | — |
| 2024 Q3 | 2024-11-14 | — | — | — | — | — | — |
| 2024 Q2 | 2024-08-14 | — | — | — | — | — | — |
| 2024 Q1 | 2024-05-15 | — | — | — | — | — | — |
| 2023 Q4 | 2024-02-14 | — | — | — | — | — | — |
| 2023 Q3 | 2023-11-14 | — | — | — | — | — | — |
| 2023 Q2 | 2023-08-14 | — | — | — | — | — | — |
| 2023 Q1 | 2023-05-15 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-14 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-14 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-11 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-16 | Sold out | — | -9,115,521 | -100.0% | — | — |
| 2021 Q2 | 2022-02-18 | New | 9,115,521 | 9,115,521 | — | $153.4M | 2.54% |
| 2021 Q3 | 2022-02-18 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | Sold out | — | -16,104,222 | -100.0% | — | — |
| 2021 Q1 | 2021-05-17 | Add | 16,104,222 | 843,710 | +5.5% | $294.1M | 4.98% |
| 2020 Q4 | 2021-02-16 | Reduce | 15,260,512 | -1,528,077 | -9.1% | $277.7M | 6.37% |
| 2020 Q3 | 2020-11-16 | Add | 16,788,589 | 593,279 | +3.7% | $299.5M | 9.40% |
| 2020 Q2 | 2020-08-14 | Reduce | 16,195,310 | -3,761,689 | -18.8% | $290.4M | 8.01% |
| 2020 Q1 | 2020-05-15 | Reduce | 19,956,999 | -10,625,722 | -34.7% | $302.9M | 8.24% |
| 2019 Q4 | 2020-02-14 | Add | 30,582,721 | 3,138,875 | +11.4% | $603.4M | 5.28% |
| 2019 Q3 | 2019-11-14 | Add | 27,443,846 | 1,013,018 | +3.8% | $472.0M | 4.97% |
| 2019 Q2 | 2019-08-14 | Add | 26,430,828 | 318,168 | +1.2% | $467.8M | 4.24% |
| 2019 Q1 | 2019-05-15 | New | 26,112,660 | 26,112,660 | — | $531.9M | 4.75% |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-15 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.